Sudarshan Pharma Industries Boards Meeting Scheduled to Discuss Q1 Financial Results for FY 2026-27
Sudarshan Pharma Industries Ltd has scheduled a meeting of its Board of Directors to review and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The board meeting is set to be held on Wednesday, August 12, 2026.The company confirmed that the purpose of the scheduled board meeting includes considering and approving the financial results pertaining to the quarter that concluded on June 30, 2026.
In relation to this announcement, Sudarshan Pharma Industries has stated that the trading window of the company will remain closed until the expiry of 48 hours following the declaration of the financial results for the quarter ending June 30, 2026.
Stock Price Movement
On Friday, shares of Sudarshan Pharma Industries Ltd settled at ₹34.00, edging up 0.03% in post-market trading. The stock moved through its range during the session, hitting a low of ₹32.30 and reaching an intraday high of ₹34.48.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.